Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History
International Journal of Pharmaceutical Sciences Research Volume 3 (2016), Article ID 3:IJPSR-115, 6 pages
http://dx.doi.org/10.15344/2394-1502/2016/115
Research Article
Suppressive Activity of Chondroitin Sulfate on Periostin Production by Synoviocytes from Knee Osteoarthritis In Vitro

Daisuke Tamaki1, Shintaro Ishikawa2, Asako Yamada3, Amane Otaki1, and Kazuhito Asano4*

1Graduate School of Health Sciences, Showa University Graduate School, Yokohama, Japan
2Department of Physiology, School of Medicine, Showa University, Tokyo, Japan
3Division of Nursing, Showa University Fujigaoka Hospital, Showa University, Yokohama, Japan
4Division of Physiology, School of Nursing and Rehabilitation Sciences, Showa University, Yokohama, Japan
Prof. Kazuhito Asano, Division of Physiology, School of Nursing and Rehabilitation Sciences, Showa University, 1865 Touka-Ichiba, Midori-Ku, Yokohama 226-8555, Japan; E-mail: asanok@med.showa-u.ac.jp
01 August 2016; 18 October 2016; 20 October 2016
Tamaki D, Ishikawa S, Yamada A, Otaki A, Asano K (2016) Suppressive Activity of Chondroitin Sulfate on Periostin Production by Synoviocytes from Knee Osteoarthritis In Vitro. Int J Pharma Sci Res 3: 115. doi: https://doi.org/10.15344/2394-1502/2016/115
© 2016 Tamaki et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. Chijimatsu R, Kunugiza Y, Taniyama Y, Nakamura N, Tomita T, et al. (2015) Expression and pathological effects of periostin in human osteoarthritis cartilage. BMC Musculoskeletal Disorders 16: 215-226. View
  2. Ishikawa S, Asano K, Kusayanagi H, Takashima M, Yoshida N, et al. (2015) Influence of periostin on synovial fibroblasts in knee osteoarthritis. Chronic Dis Int 2: 1013. View
  3. Kotlarz H, Gunnarsson CL, Fang H, Rizzo JA (2009) Insurer and out-ofpocket costs of osteoarthritis in the US: evidence from national survey data. Arthritis Rheum 60: 3546-3553. View
  4. Lohmander LS (2000) What can we do about osteoarthritis? Arthritis Res 2: 95-100. View
  5. Casagrande D, Stains JP, Murthi AM (2015) Identification of shoulder osteoarthritis biomarkers: comparison between shoulders with and without osteoarthritis. J Shoulder Elbow Surg 24: 382-390. View
  6. Horiuchi K, Amizuka N, Takeshita S, Takamatsu H, Katsuura M, et al. (1999) Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res 14: 1239-1249. View
  7. Conway SJ, Izuhara K, Kudo Y, Litvin J, Markwald R, et al. (2014) The role of periostin in tissue remodeling across health and disease. Cell Mol Life Sci 71: 1279-1288. View
  8. Takeshita S, Kikuno R, Tezuka K, Amann E (1993) Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem J 294 : 271-278. View
  9. Uchida M, Shiraishi H, Ohta S, Arima K, Taniguchi K, et al. (2012) Periostin, a matricellular protein, plays a role in the induction of chemokines in pulmonary fibrosis. Am J Respir Cell Mol Biol 46: 677-686. View
  10. Ohta N, Ishida A, Kurakami K, Suzuki Y, Kakehata S, et al. (2014) Expressions and roles of periostin in otolaryngological diseases. Allergol Int 63: 171-180. View
  11. Furuta A, Asano K, Suzuki T, Mizuyoshi T, Asano M, et al. (2015) Suppressive activity of macrolide antibiotics on periostin production from nasal cells in vitro and in vivo. Chronic Dis Int 2: 1012. View
  12. Veronesi F, Fini M, Giavaresi G, Ongaro A, Mattei M, et al. (2015) Experimentally induced cartilage degeneration treated by pulsed electromagnetic field stimulation; an in vitro study on bovine cartilage. BMC Musculoskeletal Disorders 16: 308. View
  13. Provenza JR, Shinjo SK, Silva JM, Peron CRGS, Rocha FA (2015) Combined glucosamine and chondroitin sulfate, once or three times daily, provides clinically relevant analgesia in keen osteoarthritis. Clin Rheumatol 34: 1455-1462. View
  14. Gallagher B, Tjoumakaris FP, Harwood MI, Good RP, Ciccotti MG, et al. (2015) Chondroprotection and the prevention of osteoarthritis progression of the knee: a systematic review of treatment agents. Am J Sports Med 43: 734-744. View
  15. Henrotin Y, Marty M, Mobasheri A (2014) What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis? Maturitas 78: 184-187. View
  16. Percope de Andrade MA, Campos TV, Abreu-E-Silva GM (2015) Supplementary methods in the nonsurgical treatment of osteoarthritis. Arthroscopy 31: 785-792. View
  17. Hochberg MC, Martel-Pelletier J, Monfort J, Moller I, Castillo JR, et al. (2015) Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicenter, randomized, double-blind, non-inferiority trial versus celecoxib. Ann Rheum Dis 75: 37-44. View
  18. Swartzman E, Shannon M, Lieu P, Chen SM, Mooney C, et al. (2010) Expanding applications of protein analysis using proximity ligation and qPCR. Methods 50: S23-26. View
  19. Keter FK, Kanyanda S, Lyantagaye SS, Darkwa J, Rees DJ, et al. (2008) In vitro evaluation of dichloro-bis(pyrazole)palladium(II) and dichlorobis( pyrazole)platinum(II) complexes as anticancer agents. Cancer Chemother Pharmacol 63: 127-138. View
  20. Barbacioru CC, Wang Y, Canales RD, Sun YA, Keys DN, et al. (2006) Effect of various normalization methods on Applied Biosystems expression array system data. BMC Bioinformatics 7: 533. View
  21. Martínez A, Sánchez-Lopez M, Varadé J, Mas A, Martín MC, et al. (2007) Role of the MHC2TA gene in autoimmune diseases. Ann Rheum Dis 66: 325-329. View
  22. Kósa JP, Kis A, Bácsi K, Balla B, Nagy Z, et al. (2011) The protective role of bone morphogenetic protein-8 in the glucocorticoid-induced apoptosis on bone cells. Bone 48: 1052-1057. View
  23. Volpi N (2003) Oral absorption and bioavailability of ichthyic origin chondroitin sulfate in healthy male volunteers. Osteoarthritis Cartilage 11: 433-441. View
  24. Volpi N (2002) Oral bioavailability of chondroitin sulfate (Condrosulf) and its constituents in healthy male volunteers. Osteoarthritis Cartilage 10: 768- 777. View
  25. Kubo M, Ando K, Mimura T, Matsusue Y, Mori K (2009) Chondroitin sulfate for the treatment of hip and knee osteoarthritis: current status and future trends. Life Sci 85: 477-483. View
  26. Volpi N (2010) About oral absorption and human pharmacokinetics of chondroitin sulfate. Osteoarthritis Cartilage 18: 1104-1105. View
  27. Tsuchida A, Beekhuizen M, Hart MC, Radstake T, Dhert W, et al. (2014) Cytokine profiles in the joint depend on pathology, but are different between synovial fluid, cartilage tissue and cultured chondrocytes. Arthritis Res Ther 16: 441. View
  28. Oh CK, Geba GP, Molfino N (2010) Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma. Eur Respir Rev 19: 46-54. View
  29. Chiba Y, Goto K, Misawa M (2012) Interleukin-13-induced activation of signal transducer and activator of transcription 6 is mediated by an activation of Janus kinase 1 in cultured human bronchial smooth muscle cells. Pharmacol Rep 64: 454-458. View
  30. Hakuno D, Kimura N, Yoshioka M, Mukai M, Kimura T, et al. (2010) Periostin advances atherosclerotic and rheumatic cardiac valve degeneration by inducing angiogenesis and MMP production in humans and rodents. J Clin Invest 120: 2292-2306. View
  31. Davidson RK, Waters JG, Kevorkian L, Darrah C, Cooper A, et al. (2006) Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage. Arthritis Res Ther 8: R124. View
  32. Ohta C, Yamada A, Yufune K, Asano K (2016) Suppressive Activity of Glucosamine Hydrochloride on Nitric Oxide Production from Synoviocytes In Vitro. Int J Pharma Sci Res 3: 111. View
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.